Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Roux 19/39 | |||
| KfH 2009-0010 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to observe a potential benefit of moderate physical activity by using bed mounted cycles during hemodialysis treatment sessions on inflammatory markers in the blood of patients with end-stage renal disease (ESRD).
Patients with ESRD on chronic hemodialysis patients frequently have elevated markers of inflammation (e.g., serum CRP values) and accumulation of proinflammatory monocyte populations in the circulation. The level of inflammation is highly predictive for cardiovascular disease and mortality. Physical activity has been shown to improve dialysis efficacy by improving the elimination of retention solutes. In healthy individuals, sports activity influences inflammatory immune parameters. The study will observe the influence of moderate physical activity (using a bed mounted cycle for 30min during dialysis thrice weekly) on circulating monocyte subpopulations and inflammatory proteins over a 9 month period in 16 chronic hemodialysis patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| hemodialysis patients | chronic hemodialysis patients with elevated inflammation markers |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| moderate physical activity | Behavioral | bed mounted cycles for physical activity for 30 min during each hemodialysis session |
|
| Measure | Description | Time Frame |
|---|---|---|
| Composition of monocyte subpopulations as defined by CD14 and CD16 expression | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Serum CRP values | 6 months | |
| Dialysis quality (kt/V, URR) | 6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
End-stage renal disease patients on chronic hemodialysis therapy
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Matthias Girndt, MD | Martin-Luther-University Halle-Wittenberg, Germany | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Internal Medicine II | Halle | Saxony-Anhalt | D06120 | Germany |
Not provided
| ID | Term |
|---|---|
| D007676 | Kidney Failure, Chronic |
| D007249 | Inflammation |
| D002318 | Cardiovascular Diseases |
| ID | Term |
|---|---|
| D051436 | Renal Insufficiency, Chronic |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Serum and DNA samples
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |